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Introduction {#sec1}
============

With the increasing prevalence of diabetes mellitus, interest in the development and function of the pancreas remains intense ([@bib9]). Although much has been learned about the molecular regulators of exocrine and endocrine specification, our understanding of the morphological events that generate the patterned organ remain limited. However, using a combination of immunohistochemistry and functional genetic lineage tracing assays in mice, the pathways involved in the differential fate specification of the embryonic pancreas have begun to emerge ([@bib44], [@bib16], [@bib37], [@bib33], [@bib19], [@bib18], [@bib29]).

In mice, the program of pancreas specification is initiated around embryonic day (E) 8.5. This is followed by the formation of ventral and dorsal buds from either side of the foregut at E9.5--10 ([@bib28], [@bib35]). At this stage of development, epithelial cells are thought to retain multi-lineage potential, capable of differentiating into all three major pancreatic cell types: ductal, acinar, and islet ([@bib28], [@bib35]). Around E12.5, the developing pancreas transfers into a "secondary transition" phase in which the expression profiles of precursors segregate into "tip-trunk" domains, orchestrated by Nkx6.1/Ptf1a cross-repression ([@bib33]), forming a central multi-lumen tubular plexus ([@bib28]) ([Figure 1](#fig1){ref-type="fig"}A). Then, through an extensive phase of branching morphogenesis, outgrowths from the plexus expand into an arbor of growing pancreatic ducts.Figure 1Quantitative Lineage Tracing Reveals Evidence of Early Lineage Commitment of Heterogeneous Pancreatic Precursors(A) Schematic depicting key stages in pancreas development.(B) Schedule of lineage tracing experiments using the *Rosa26*-CreERT2/*Rosa26*-Confetti mice.(C) Thick 100-μm section of P14 pancreas induced at E9.5.(D) Zoom on tripotent RFP clone from (C), containing islet, acinar, and ductal components (indicated by an arrowhead, asterisk, and arrow, respectively) with zoom on single Z-sections demonstrating the contribution of clones to different pancreatic compartments.(E) Thick 100-μm section of P14 pancreas induced at E12.5 reveals heterogeneous clonal outcomes of various potencies.(F) Acinar majority nGFP clone from (E) (acinar compartment indicated with an asterisk) surrounding a network of ducts with rare labeled ductal cells (indicated by arrow) and shown in zoom on single Z-section. High-resolution images were used in (D)--(F) for the assessment of potency.(G) Low-resolution image of a small cYFP clone from (E) containing a few cells.(H) Representative unipotent acinar-only cRFP clone from (E) surrounding unlabeled ducts. The lack of overlap between clone and ducts is indicated in single Z-section images on the right.(I) Ductal-only mCFP clone from (E) containing monoclonal ducts (indicated by arrow) and ductal overlap shown on single Z-sections on the right.(J) Bipotent cRFP clone from (E) in red (cRFP) (islet and ductal compartments indicated by an arrowhead and arrow, respectively).(K) Global potency of clones induced at E9.5 and E12.5, indicating a shift toward unipotency.(L) Fraction of unipotent clones versus induction probability for each confetti color. Bars indicate mean and SD. Nuclei stained with DAPI (blue), islets immunostained using chromogranin A antibody (white), and ducts stained with DBA (white). While 41 clones were counted from n = 3 mice for the E9.5 to P14 tracing, 254 clones were counted from n = 3 mice for the E12.5 to P14.(M) Comparison of global potency between both quantification methods ([Figures S2](#mmc1){ref-type="supplementary-material"}O and S2P) showed no statistically significant difference in the potency outcome (P = 0.37, Chi-square test; 53 clones from n = 4 mice). See also [Figures S1--S6](#mmc1){ref-type="supplementary-material"}; [Videos S1](#mmc3){ref-type="supplementary-material"}, [S2](#mmc4){ref-type="supplementary-material"}, [S3](#mmc5){ref-type="supplementary-material"}, and [S4](#mmc6){ref-type="supplementary-material"}; and [Table S1](#mmc2){ref-type="supplementary-material"}.

During the phase of tip-trunk segregation, tip cells are thought to become restricted to acinar fate ([@bib44]), while trunk cells give rise to ductal cells as well as Ngn3+ endocrine-committed cells ([@bib37], [@bib16]) ([Figure 1](#fig1){ref-type="fig"}A). However, lineage tracing studies based on Cpa1 expression in tip cells and Hnf1β expression in trunk cells suggest that both domains retain tripotent precursors until at least E13.5 ([@bib44], [@bib37]). Indeed, tracing studies of Sox9-expressing cells suggest that tripotent cells may persist even after birth ([@bib19], [@bib11]). Yet, since these genetic labeling studies have sought to address the lineage potential of cells at the population scale ([@bib44], [@bib37], [@bib19]), the question of whether and how these findings hold at the level of individual cells remain unclear. Recently, a clonal lineage tracing study based on the use of ubiquitous and gene-specific promoters has argued that pancreatic founder cells may become sub-lineage-restricted as early as E9.5 ([@bib21]), with evidence for early commitment to the ductal and islet lineages. However, clonal tracing studies spanning the entire developmental time window remain unaddressed.

The interpretation of static lineage tracing data as a reflection of cell potency and histogenesis is further confounded by the large-scale cell rearrangements that take place during pancreatic morphogenesis. Combining genome-wide transcription factor expression analysis with clonal tracing studies, Zhou et al. have argued that the first phase of ductal branching is controlled by multipotent Pdx1^+^Pft1a^+^cMyc^High^Cpa1^+^ progenitors located within tip domains that give rise to acinar cells and fate-restricted trunk cells that form the trailing ducts and islets ([@bib44]). However, the question of whether and how these progenitors act collectively to coordinate the prolonged phase of branching morphogenesis ([@bib3]) remains unclear: how does cell fate restriction during development correlate with changes in the proliferative potential of progenitors to achieve spatio-temporal patterning of tissue? To what extent do the mechanisms of fate specification and ductal patterning in pancreas mirror the morphogenesis of other branched organs such as the lung, mammary gland, or kidney ([@bib15])?

Here, by combining clonal lineage tracing using whole-mount reconstructions with proliferation kinetics, single-cell gene expression profiling, and quantitative biophysical modeling, we define both the lineage hierarchy and the spatio-temporal dynamics of pancreatic precursors during development. Based on the statistical properties of the complex branched ductal network, we use these insights to develop a theoretical basis to understand the large-scale organization of the pancreas. Finally, by drawing a quantitative comparison with the statistical organization of the mouse mammary gland ductal epithelium, we argue that the basic mechanism of ductal patterning is conserved across different tissues.

Results {#sec2}
=======

Clonal Lineage Tracing Provides Evidence for Early and Progressive Lineage Restriction {#sec2.1}
--------------------------------------------------------------------------------------

To study the lineage and proliferative potential of pancreatic precursors, previous studies have exploited transgenic mouse models based on targeted promoters ([@bib44], [@bib37], [@bib19], [@bib18], [@bib29]). Here, to capture the dynamics of precursors in an unbiased manner, we made use of the *Rosa26*-CreERT2/*Rosa26*-Confetti mouse model to label all cell types in the developing pancreas ([Figures 1](#fig1){ref-type="fig"}B--1J and [S1](#mmc1){ref-type="supplementary-material"}A--S1L), turning later to consider a cell-specific promoter. To monitor changes in the potency of precursors and the dynamics driving branching morphogenesis, clones were induced around the start of the two key stages of development, E9.5 and E12.5 ([Figures 1](#fig1){ref-type="fig"}A and 1B). However, due to the time delay in activating and clearing Tamoxifen ([@bib26], [@bib12]), we note that cells could be induced as much as a day after injection. To achieve clonal density labeling, we titrated the Tamoxifen dose so that labeled cells were scarce (\<3% by volume using Tamoxifen injection at 0.025 mg/g of pregnant female for E12.5 induction, [Figures S1](#mmc1){ref-type="supplementary-material"}M--S1O; 0.020 mg/g for E9.5 induction). Tissue was then harvested at post-natal day (P) 14 and P28, and clones were reconstructed in 3D using thick serial sections ([Figures 1](#fig1){ref-type="fig"}C--1J, [S1](#mmc1){ref-type="supplementary-material"}B--S1O, and [Videos S1](#mmc3){ref-type="supplementary-material"}, [S2](#mmc4){ref-type="supplementary-material"}, [S3](#mmc5){ref-type="supplementary-material"}, and [S4](#mmc6){ref-type="supplementary-material"}).

Video S1. 3D Reconstruction of a Typical Acinar-Majority nGFP "Cauliflower-Like" Clone Showing the Association of Labeled Aciar Cells Associated with the Same Ductal Subtree, Related to Figure 1Ducts in White (DBA). Same as Figure 1F. Scale bar represents 50 μm.

Video S2. 3D Reconstruction of a Typical Acinar-Only cRFP Clone, Related to Figure 1Ducts in White (DBA). Same as Figure 1H. Scale bar represents 30 μm.

Video S3. 3D Reconstruction of a Typical Ductal-Acinar mCFP Clone, Related to Figure 1Ducts in White (DBA). Same as Figure 1I. Scale bar represents 30 μm.

Video S4. 3D Reconstruction of a Typical Ductal-Acinar mYFP Clone, Related to Figure 1Ducts in White (DBA). Scale bar represents 30 μm

By exploiting the confetti labeling system to control for potential clone merger and fragmentation events, we used a rigorous assessment to identify clones with defined statistical confidence ([Figure S2](#mmc1){ref-type="supplementary-material"} and [STAR Methods](#sec4){ref-type="sec"}). Additionally, we verified that our assessments of potency were independent of the color quantified, even though there was a nearly 10-fold difference in the GFP (green fluorescent protein) and RFP (red fluorescent protein) induction frequency. Clones were quantified with respect to position, size (by volume), and cell composition based on chromogranin A (islet), Dolichos biflorus agglutinin (DBA, ductal), and DAPI (nuclear staining, 4′,6-diamidino-2-phenylindole) staining ([Figures 1](#fig1){ref-type="fig"}C--1J and [S1](#mmc1){ref-type="supplementary-material"}; [STAR Methods](#sec4){ref-type="sec"}). Throughout, our assessments of cell composition were obtained from the analysis of high-resolution images. Amylase staining confirmed that nearly all non-ductal and non-islet cells of the dissected pancreas at the stages analyzed were of acinar type ([Figures S3](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}A--S4C). Ductal and islet lineages could also be clearly distinguished morphologically when stained in a single channel, based on control stainings ([Figures S4](#mmc1){ref-type="supplementary-material"}D--S4F). To further verify the integrity of lineage assignments and exclude the possibility that clones arose from non-pancreatic lineages such as stroma, endothelium, or nerves, we confirmed our results quantitatively with an additional and independent clonal analysis using amylase, chromogranin A, and DBA co-immunostaining ([Figure S3](#mmc1){ref-type="supplementary-material"} and [STAR Methods](#sec4){ref-type="sec"}). Finally, we checked that the overall increase in average clone size of the acinar compartment ([Figure S2](#mmc1){ref-type="supplementary-material"}L) tracked proportionately the increase of pancreas volume between E13.5, P14, and P28 ([Figures S2](#mmc1){ref-type="supplementary-material"}M and S2N), confirming the representative nature of the clonal tracing assay and the integrity of clonal assignment.

From clonal reconstructions, two features were common to both early and late induction and collection times. First, clones remained remarkably cohesive in both ductal and acinar compartments ([Figures 1](#fig1){ref-type="fig"}C--1J, [S1](#mmc1){ref-type="supplementary-material"}B--S1O; [Videos S1](#mmc3){ref-type="supplementary-material"}, [S2](#mmc4){ref-type="supplementary-material"}, [S3](#mmc5){ref-type="supplementary-material"}, and [S4](#mmc6){ref-type="supplementary-material"}), indicating that despite large-scale cell rearrangements, the dispersion of proximate cells during the secondary transition between disconnected ductal branch structures must be limited; however, a degree of bidirectional dispersion of cells along a connected ductal branch could not be ruled out. Second, clones were observed over a wide range of sizes, with some containing thousands of cells spanning large areas of tissue, whereas others contained only a few cells; many clones displayed a branching morphology ([Figures 1](#fig1){ref-type="fig"}F, 1G, and [S5](#mmc1){ref-type="supplementary-material"}A--S5C).

Based on cell composition, we identified uni-, bi-, and tripotent clones, with permutations across all three lineages ([Figures 1](#fig1){ref-type="fig"}D, 1F--1J, [S5](#mmc1){ref-type="supplementary-material"}D--S5F, [S2](#mmc1){ref-type="supplementary-material"}O, and S2P). Strikingly, examining the composition of clones traced from E12.5 to P14 and P28, we found that the majority were unipotent, based on chromogranin A, DBA, and amylase stainings (68% at P14 and 72% at P28; [Figures 1](#fig1){ref-type="fig"}K--1M, [S5](#mmc1){ref-type="supplementary-material"}D, and S5E). (For a complete list of clone types and sizes, see [Table S1](#mmc2){ref-type="supplementary-material"} and [Figures S2](#mmc1){ref-type="supplementary-material"}O, S2P, [S5](#mmc1){ref-type="supplementary-material"}D, and S5F.) This argues that the lineage potential of most precursors has already become restricted by E12.5, contrasting with previous findings ([@bib44], [@bib37], [@bib19], [@bib11]). Indeed, these results suggest that reports of extensive tripotency as late as E12.5--14.5 may be an artefact of high-density labeling, tracing the evolution of populations instead of individual cells. Examination of the clonal composition from the E9.5 to P14 tracing ([Figures 1](#fig1){ref-type="fig"}K and [S5](#mmc1){ref-type="supplementary-material"}F) performed under the same conditions revealed that the majority of clones remained bi- or tripotent (64%), as expected from the lack of tip-trunk segregation at this early stage of development ([@bib28]). Yet, even at this time point, some 25% of induced cells generated unipotent clones (see [Discussion](#sec3){ref-type="sec"}).

Could heterogeneity in potency explain the wide variability of clone sizes, with multipotent progenitors giving rise to large clones and unipotent progenitors generating small clones? Although multipotent clones were, on average, slightly larger than unipotent clones, each category still contained clones spanning three orders of magnitude in size ([Figure S5](#mmc1){ref-type="supplementary-material"}B), suggesting that the observed heterogeneity does not derive from the labeling of distinct progenitor types within a developmental hierarchy. Therefore, to understand the source of clone size heterogeneity and gain insight into the dynamics and large-scale patterning of tissue during the secondary transition, we examined the location and spatial organization of clones.

Branching Morphogenesis Is Driven by Both Multipotent and Fate-Restricted Precursors Localized at Ductal Termini {#sec2.2}
----------------------------------------------------------------------------------------------------------------

We first considered whether the specification of the pancreas relies on an early phase of expansion that precedes plexus remodeling or whether the bulk of expansion takes place through the later phase of ductal branching once the plexus is formed. We reasoned that if clonal expansion occurs mainly before plexus remodeling, clones would become fragmented and dispersed across adjacent ductal subtrees. If, on the other hand, ductal expansion is derived from the activity of precursors localized to side-branches of the plexus, clones induced at E12.5 would track segments of individual ductal subtrees (see [Figure 2](#fig2){ref-type="fig"}A for a schematic, where subtrees are identified as the connected networks of branches and sub-branches emanating from central ducts.). Notably, we found that the vast majority of ducts that contained labeled cells (ca. 80%) were characterized by a high degree of monoclonality ([Figure 2](#fig2){ref-type="fig"}B) and that these clonally labeled ducts were restricted to the same subtree, generally extending to the periphery of the ductal network ([Figures 2](#fig2){ref-type="fig"}B and [1](#fig1){ref-type="fig"}I). Remarkably, we also found that the majority (ca. 90%) of acinar cell-containing clones, including unipotent (acinar-only) clones, were closely associated with single ductal subtrees across multiple generations of consecutive branching events ([Figures 2](#fig2){ref-type="fig"}C, [1](#mmc1){ref-type="supplementary-material"}F, and 1H), indicating a tight correlation between the branching program and the expansion of the acinar compartment. Importantly, ductal and acinar clones at the periphery of the pancreas were consistently larger and more branched than clones in the center (p \< 0.01, Mann-Whitney test, [Figure S5](#mmc1){ref-type="supplementary-material"}C). Together, these results suggest that during the secondary transition phase, pancreas development follows a coordinated process of branching morphogenesis, driven by precursors at, or near, the termini of ducts that self-renew through serial rounds of branching, giving rise to proliferative cells that form the trailing ducts as well as acinar cells that associate with the ends of terminated ducts.Figure 2Morphology and Potency of Clones Reveal Evidence for Ductal End-Driven Branching Morphogenesis(A) Schematic depicting the different types of clones that would be expected to arise during pancreatic development being driven either solely by plexus remodeling or by ductal end-driven branching morphogenesis.(B) Ductal branching clone, monoclonally labeling the distal parts of ducts with zoomed-in single Z-section on the right showing the overlap of DBA with cYFP. Ducts indicated with an arrow.(C) Ductal terminus-associated acinar clone with acinar cells (asterisk) closely surrounding ducts stained with DBA (white, arrow), zoomed-in single Z-section on the right showing a very small overlap of DBA with cYFP.(D--F) Schematics demonstrating the distinct clone morphologies arising from the labeling of different types of ductal-end precursors, with (D) depicting a tripotent clone, (E) a unipotent ductal clone, and (F) a unipotent acinar clone.(G and H) Potency of (G) acinar cell- and (H) ductal cell-containing clones induced at E12.5. Ductal cells remain bi- and tripotent, whereas acinar precursor clones become increasingly lineage-committed.(I and J) Ductal-terminus associated tripotent cRFP (I) and bipotent cRFP (J) clones. Islet, ductal, and acinar compartments indicated by an arrowhead, arrow, and asterisk, respectively. See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc2){ref-type="supplementary-material"}.

We then assessed the fate potential of self-renewing precursors at the ductal termini. Concentrating on the E12.5 induction, we reasoned that if branching morphogenesis is driven by multipotent progenitors, clones tracking whole subtrees should contain a mixture of acinar and ductal cells (see schematic in [Figure 2](#fig2){ref-type="fig"}D). If, on the other hand, branching morphogenesis is driven by the coordinated dynamics of fate-restricted progenitors as occurs, for example, during the pubertal development of mouse mammary gland ([@bib34]), clones tracking whole ductal subtrees should be of either purely acinar or ductal type ([Figures 2](#fig2){ref-type="fig"}E and 2F). In support of the second hypothesis, some 70% of acinar-containing clones induced at E12.5 were found to be unipotent ([Figure 2](#fig2){ref-type="fig"}G, as well as [Figure S5](#mmc1){ref-type="supplementary-material"}G for E9.5 induction). The fact that these clones often spanned multiple rounds of consecutive branching of the same ductal subtree suggests that acinar cells arise from acinar-committed precursors that associate with ductal termini and undergo renewal during ductal bifurcation ([Figure 2](#fig2){ref-type="fig"}F). By contrast, the vast majority of ductal cell-containing clones traced from E12.5 were found to be multipotent ([Figure 2](#fig2){ref-type="fig"}H, as well as [Figure S5](#mmc1){ref-type="supplementary-material"}H for E9.5 induction) and included tripotent clones ([Figures 2](#fig2){ref-type="fig"}I and [S1](#mmc1){ref-type="supplementary-material"}J), bipotent ductal-acinar clones with typically sparsely labeled ductal cells ([Figures 1](#fig1){ref-type="fig"}F and [S1](#mmc1){ref-type="supplementary-material"}G--S1I), as well as some bipotent ductal-islet clones ([Figure 2](#fig2){ref-type="fig"}J). Altogether, these findings suggest that at E12.5, growing ductal termini host both multipotent progenitors and fate-restricted acinar and ductal progenitors, which act cooperatively to drive pancreatic growth.

While clonal tracings based on a ubiquitous promoter allow for an unbiased assessment of lineage potential, it does not reveal whether the potency of cells correlates with defined molecular signatures. Therefore, to consolidate our findings, we turned to a targeted lineage tracing strategy using a *Sox9*-CreERT2 mouse model ([@bib19]). Although Sox9 expression has been associated with tripotency ([@bib19], [@bib11]), an examination of clones induced at E12.5 at low induction frequency (Tamoxifen injection at 0.025 mg/g of pregnant female) revealed morphologies and potencies qualitatively similar to that found using the *Rosa26* model (compare [Figures 3](#fig3){ref-type="fig"}A, 3B, [S5](#mmc1){ref-type="supplementary-material"}K--S5O with [Figures 2](#fig2){ref-type="fig"}B and 2C), identifying tree shaped clones ([Figures S5](#mmc1){ref-type="supplementary-material"}K--S5O), with a slight majority of individual *Sox9*-targeted cells already fate-restricted to either the acinar or ductal-islet lineage. As expected, when compared to the *Rosa26* tracing, we noticed an enrichment of multipotent clones ([Figures S5](#mmc1){ref-type="supplementary-material"}P--S5R, p \< 0.0001, chi-square test) and ductal cell-containing clones ([Figure S5](#mmc1){ref-type="supplementary-material"}S, p \< 0.0001, chi-square test), arguing that *Sox9* targets a heterogeneous cell population biased toward the ductal lineage. As well as supporting the representative character of the Rosa26 tracings, these findings further emphasize the importance of using a clonal assessment of cell fate potential.Figure 3Establishing the Hierarchy of Progenitor Cells in the Pancreas(A and B) *Sox9*-CreERT2; *Rosa26*-Confetti lineage tracing recapitulates the basic morphology and cell type composition of clones in [Figures 2](#fig2){ref-type="fig"}B and 2C with both (A) branched ductal clones and (B) acinar subtree-associated clones present in abundance, supporting the hypothesis that self-renewing ductal and acinar precursors at ductal termini drive pancreatic branching morphogenesis. Ductal and acinar compartments are indicated by an arrow and asterisk, respectively.(C and D) Comparison of sub-clone sizes in the acinar (C) and ductal (D) compartment for unipotent versus bi- or tripotent clones. Bars indicate mean and SD.(E) Hierarchy of multipotent precursors and their lineage-restricted progeny inferred from lineage tracing data.(F--H) Evolution of pancreatic ductal network stained in whole-mount with Dolichos biflorus agglutinin (DBA) at (F) E13.5, (G) E15.5, and (H) E18.5. Central plexus indicated in outline by dashed blue lines. See also [Figure S5](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc2){ref-type="supplementary-material"}.

We then investigated whether the fate-restriction of pancreatic precursors was accompanied by a decreased proliferative potential. Strikingly, we found that although there were differences between the average size of unipotent clones and that of bi- or tripotent clones (for both the ductal and acinar compartments), these differences were small (2-fold maximum) compared to the large clone size heterogeneity (spanning four orders of magnitude) ([Figures 3](#fig3){ref-type="fig"}C and 3D). This shows that self-renewing fate-restricted acinar and ductal precursors retained a growth potential similar to that of multipotent self-renewing progenitors. This observation implies that the former must be specified early in development (during tip-trunk segregation) and are replenished by the latter only rarely during the later stages of development.

In summary, the potency and spatial organization of clones are suggestive of a cellular hierarchy in which, during the secondary transition, minority populations of both multipotent and fate-restricted self-renewing precursors localized to growing ductal termini act in concert to coordinate a process of branching morphogenesis. This gives rise to ductal progenitors that locally expand the maturing ducts, as well as to delaminating islet precursors ([Figure 3](#fig3){ref-type="fig"}E).

Correlation of the Distribution of Clone and Ductal Subtree Sizes Suggests that They Share a Common Origin {#sec2.3}
----------------------------------------------------------------------------------------------------------

To understand the origin of clone-size heterogeneity, we turned to a quantitative analysis of the clone size distributions ([Figure S6](#mmc1){ref-type="supplementary-material"}). Comparison of ductal and acinar cell-containing clones showed that the size distributions of the respective compartments, rescaled by the average clone size, was strikingly similar both between lineages at P14 ([Figures S6](#mmc1){ref-type="supplementary-material"}A--S6C, p = 0.68, Mann-Whitney test), as well as within the same lineage between the P14 and P28 collection time points ([Figure S6](#mmc1){ref-type="supplementary-material"}D, p = 0.63 for acinar and p = 0.95 for ductal, Mann-Whitney tests; [STAR Methods](#sec4){ref-type="sec"}). That is, while their average sizes differ by more than an order of magnitude (E12.5 to P14 tracing), the chance of finding a clone larger than some multiple of the average remains the same for both the acinar and ductal lineage; and the same was true for E9.5-traced clones ([Figures S6](#mmc1){ref-type="supplementary-material"}E--S6H). This suggests that the gross heterogeneity in clone sizes of the acinar and ductal compartments may share a common origin in the chance collective fate decisions of self-renewing progenitors during the phase of branching morphogenesis.

To challenge this hypothesis, we assessed the emergence and degree of gross heterogeneity of the growing ductal network itself. In line with previous reports ([@bib32], [@bib17], [@bib40], [@bib3], [@bib36]), an analysis of whole-mount tissue at E13.5 and E15.5 revealed a transition from a plexus structure to central ducts from which multiple smaller ducts start to branch ([Figures 3](#fig3){ref-type="fig"}F and 3G). By E18.5, whole-pancreas ductal reconstructions revealed a strikingly complex and intricate ductal network, reflecting multiple (\>10) rounds of serial branching events tracking back to the central duct ([Figure 3](#fig3){ref-type="fig"}H), consistent with a phase of branching morphogenesis. Notably, focusing on measurements made from whole-mounts at E18.5, we found that some ductal subtrees remain small and localized to the center of the pancreas and comprise only a limited number of branch segments ([Figure 4](#fig4){ref-type="fig"}A, arrow). By contrast, other subtrees expanded radially, reaching out to the periphery of the organ and colonizing a large volume of tissue ([Figure 4](#fig4){ref-type="fig"}A, arrowhead). We then quantified the raw distribution of subtree sizes, defined as the total number of branches (i.e., segments between two bifurcation points) within each subtree emanating from the central ducts ([Figures 4](#fig4){ref-type="fig"}B and 4C). Strikingly, when compared to the clonal data, we found that the rescaled subtree size distribution matched closely the rescaled clone size distributions of both the ductal and acinar compartments ([Figure 4](#fig4){ref-type="fig"}D), suggesting that clone size heterogeneity indeed derives from the stochasticity of the branching process.Figure 4Correlation of the Distribution of Clone and Ductal Subtree Sizes Suggests that They Share a Common Origin(A) Branching structure of an E18.5 pancreas (ducts stained by DBA, white), with an arrow and arrowhead pointing to a small and large subtree, respectively, with insets i-ii highlighting the heterogeneity of branch and subtree sizes.(B) Zoomed-in image of two pancreatic subtrees of E18.5 pancreas (left) and a sketch of the two branches used in subtree size quantification (right), demonstrating the heterogeneity of branching morphogenesis. Subtrees are identified as a duct and its daughter ducts diverging from the central duct.(C) Subtree sizes (scored by the number of branches arising from a large central duct) determined from E18.5 pancreas. Bars indicate mean and SD.(D) Cumulative size distribution of ductal and acinar clones induced at E12.5, overlaid with the cumulative subtree size distribution (number of branches) determined from E18.5 pancreas. Distributions were determined from sizes rescaled by the ensemble average size, e.g., the point at (3,0.1) indicates that some 10% of clones or subtrees have a size three times larger than the average, etc. Bars indicate mean and SD.(E) Sketch of the three theoretical rules used to model pancreatic branching morphogenesis: active ductal termini (red) elongate and branch stochastically as a default state, giving rise to less proliferative ductal cells (black) that contribute to the local expansion of the trailing ductal network, whereas ducts irreversibly terminate when in proximity to other ducts.(F) Left to right: snapshots from the model simulation, starting from 40 active ductal termini initiating as side branches from a central duct, which create a complex branching structure in a self-organized manner.(G) Theoretical subtree size distribution based on 500 simulations, such as that shown in (F), compared to the experimental subtree distribution, showing quantitative agreement. Thin lines represent the 95% confidence interval. For details of the model implementation, see [STAR Methods](#sec4){ref-type="sec"}. Bars indicate mean and SD.(H) Schedule of EdU incorporation experiments.(I--N) Short-term (2-hr) EdU-incorporation shows proliferative activity of ductal and acinar cells. Top: whole-mount pancreatic ducts (stained for DBA, white; and EdU, green); bottom: ductal surface reconstruction (blue) with ductal EdU+ cells marked in red. At E13.5 (I and J), proliferation is evenly distributed throughout the ducts (n = 3 mice) whereas, at E15.5 (K and L), proliferation occurs predominantly at the periphery of the pancreas in the tip regions of ducts (n = 3 mice, arrowheads). At E18.5 (M and N), proliferation patterns become heterogeneous with some regions displaying ductal end-enrichment (n = 4 mice, arrowheads, left), while others proliferate more homogeneously (n = 5 mice, arrows, right). See also [Figure S6](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc2){ref-type="supplementary-material"}.

Dynamics of Branching Morphogenesis {#sec2.4}
-----------------------------------

Altogether, these findings suggest that during the phase of branching morphogenesis, clonal dynamics may be more usefully understood at the "mesoscopic level," thereby focusing on the organizing principles directing the collective cell dynamics of the ducts rather than the individual fate decisions of their constituent cells. To proceed, we therefore sought to define a minimal model that captured the dynamics of the ductal branching process. To this end, we noted that morphogenesis takes place in a largely two-dimensional setting ([Figures S2](#mmc1){ref-type="supplementary-material"}L--S2N), with ductal branches showing remarkably few crossovers above and below each other ([Figure 4](#fig4){ref-type="fig"}A). Moreover, ductal subtrees with small numbers of branches extended very little spatially and often terminated abruptly when "shadowed" by much larger and expanding subtrees. Based on these observations, we proposed a quantitative model where equipotent ductal termini, initiating as side-branches from a few central, plexus-derived ducts specified early in development, drive a process of stochastic ductal branching and elongation, which terminates when termini move into proximity of neighboring ducts. Specifically, we asked whether this model, whose sole key parameter is the measured average separation of independent adjacent subtrees along the central duct, could recapitulate quantitatively the observed subtree growth heterogeneity, as has been shown previously for mouse mammary gland and kidney ([@bib14]), without the need to invoke the existence of engrained cellular heterogeneity (see [STAR Methods](#sec4){ref-type="sec"} for details).

Notably, numerical simulations of the model showed that, consistent with experiment, (1) active ductal termini "self-organize" during development into a traveling pulse at the periphery of the expanding ductal network, while central regions are formed at a roughly constant density ([Figures 4](#fig4){ref-type="fig"}E and 4F); and (2) some subtrees become rapidly overshadowed by neighbors, terminating early, while others expand to host hundreds of branch segments formed over multiple generations of branching. Strikingly, a comparison of the subtree size distribution revealed a nearly perfect agreement between the model prediction and experiment (*R*^2^ = 0.99, [Figures 4](#fig4){ref-type="fig"}G and [S6](#mmc1){ref-type="supplementary-material"}I--S6K; [STAR Methods](#sec4){ref-type="sec"}). This shows that the statistical heterogeneity of pancreas subtree (as well as clone) sizes can be explained quantitatively by a simple paradigm in which all ductal termini have *a priori* the same growth potential, but their branching activity is terminated by arresting signals from neighboring ducts.

To probe the second prediction from the model, we studied proliferation within ducts, using short-term EdU incorporation (2-hr chase) and whole-mount imaging at E13.5, E15.5, and E18.5 ([Figure 4](#fig4){ref-type="fig"}H). At E13.5, we found a uniform pattern of proliferation ([Figures 4](#fig4){ref-type="fig"}I and 4J). However, at E15.5, ductal proliferation (and, to a lesser degree, acinar proliferation) was greater in peripheral regions of ductal subtrees, with an enrichment of activity at the ends of ducts ([Figures 4](#fig4){ref-type="fig"}K and 4L, arrowheads), consistent with ductal end-driven morphogenesis and the predictions of the model ([Figure 4](#fig4){ref-type="fig"}F). At E18.5, EdU showed a more heterogeneous pattern, with some parts of the pancreas characterized by enhanced proliferation at ductal termini ([Figures 4](#mmc1){ref-type="supplementary-material"}M and 4N, arrowheads), while other regions were characterized by a more uniform low-level of proliferation ([Figures 4](#mmc1){ref-type="supplementary-material"}M and 4N, arrows). Together, these results support the hypothesis that the early stages of branching morphogenesis (around E15.5) are fueled by self-renewing precursors positioned at ductal termini, which drive a process of ductal elongation and bifurcation while, at later stages, growth is dominated by the local expansion of ducts, as well as acini and islets.

Based on these insights, we then turned to consider the number of self-renewing precursors within a given ductal terminus. Since the ends of ducts appeared roughly constant in size throughout development and were frequently cleft-shaped ([@bib3]), we posited that ductal bifurcation segregates precursors approximately equally, after which they undergo a round of symmetric duplication to recover their original size. Using the inferred branching dynamics, we then simulated clonal dynamics based on the random segregation of labeled cells ([@bib34]). Chance segregation and expansion of clonally labeled precursors during ductal bifurcation allows the fraction of lineage-labeled cells in newly-formed ducts to "drift" in size, leading to a gradual process of "monoclonal conversion" in which, with increasing branch generation along the network, ducts eventually become either fully labeled by a single confetti color or completely unlabeled ([Figure 5](#fig5){ref-type="fig"}A). Importantly, the rate of monoclonal conversion along the ducts is predicted to scale in inverse proportion to the number of self-renewing ductal precursors contained in each terminus ([Figures 5](#fig5){ref-type="fig"}A, 5B, [S6](#mmc1){ref-type="supplementary-material"}L, and S6M; [STAR Methods](#sec4){ref-type="sec"}).Figure 5Branching Morphogenesis in the Ductal Termini Is Driven by a Small Number of Self-Renewing Progenitors(A) Schematic depicting the process of monoclonal conversion.(B) Model simulation of a subtree containing 4 self-renewing ductal precursors per ductal terminus with one initially labeled precursor cell (for details, see [STAR Methods](#sec4){ref-type="sec"}).(C) Representative ductal cYFP clone showing monoclonal conversion; the direction of ductal growth is indicated with an arrow. Comparison with simulations, (B) and [Figures S1](#mmc1){ref-type="supplementary-material"}J--S1L, suggest that growing ductal termini are composed of as few as 4 self-renewing ductal precursors.(D) Outline of experiment with induction at E15.5 and E18.5.(E) Clones induced at E15.5 and E18.5 were mainly unipotent.(F--H) P14 pancreas induced at E15.5 showing only a few rounds of branching events in (F) ductal and (G) acinar compartment. In addition to unipotent clones as in (E) and (F), bipotent ductal-acinar clones were also observed (H).(I--J) P14 pancreas induced at E18.5, revealing only a single bifurcation event within traced clones and unipotency in the (I) ductal and (J) acinar compartments. Ductal and acinar compartments indicated by an arrow and asterisk, respectively. 78 clones were counted from n = 2 mice for E15.5 to P14 tracing, and 61 clones were counted from n = 2 mice for E18.5 to P14 tracing. See also [Figure S6](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc2){ref-type="supplementary-material"}.

An inspection of the experimental data showed that labeled subtrees are initially "mosaic" (both in the acinar and ductal compartments), containing both labeled and unlabeled cells but showing evidence of rapid monoclonal conversion along the ductal network so that, in many cases, more distal ends are entirely comprising confetti+ cells marked by a single color ([Figures 2](#fig2){ref-type="fig"}B, 2C, and [S1](#mmc1){ref-type="supplementary-material"}J--S1L). Importantly, the clonal data suggested that in contrast to the large number of fate-restricted "stem cells" hosted in each active terminal end-bud of the mammary gland epithelium ([@bib34]), pancreatic branching morphogenesis is reliant on ductal termini hosting as a few as 4--6 self-renewing ductal precursors ([Figures 5](#fig5){ref-type="fig"}B and 5C; [STAR Methods](#sec4){ref-type="sec"}). Note that here we apply a functional definition of self-renewing progenitors as cells that contribute long-term to the development of a subtree via branching morphogenesis. Although we cannot rule out the possibility that self-renewing progenitors shuttle back and forth between ductal termini and the proximate branch, as observed during kidney morphogenesis ([@bib27]), to ensure that they are appropriately replicated during ductal bifurcation, it seems most likely that self-renewing progenitors lie clustered at the distal end of the terminus, which constitutes a localized niche.

Finally, to better characterize the temporal dynamics of branching morphogenesis, we analyzed clones induced at other developmental time points ([Figure 5](#fig5){ref-type="fig"}D), which revealed that branching was far less prevalent at later stages of development ([Figures 5](#fig5){ref-type="fig"}E--5J, [S5](#mmc1){ref-type="supplementary-material"}I, and S5J). Tracing from E15.5 to P14, we observed smaller clones that still tracked subtrees over several rounds of consecutive branching events, albeit less frequently and forming smaller trees than at E12.5 (p = 0.01, Mann-Whitney test, [Figures S5](#mmc1){ref-type="supplementary-material"}I and S5J). These clones were either of unipotent ductal ([Figure 5](#fig5){ref-type="fig"}F) or acinar ([Figure 5](#fig5){ref-type="fig"}G) composition or, more rarely, of bipotent ductal-acinar or islet-ductal composition ([Figures 5](#fig5){ref-type="fig"}E, 5H and [S6](#mmc1){ref-type="supplementary-material"}N). Tracing from E18.5 to P14, we found that clones displayed minimal but non-vanishing (ductal-acinar) bipotency and were even less branched ([Figures 5](#fig5){ref-type="fig"}E, 5I, 5J, [S5](#mmc1){ref-type="supplementary-material"}I, S5J, and [S6](#mmc1){ref-type="supplementary-material"}O), consistent with branching morphogenesis being superseded by a process of expansion via local dilation of an existing tree structure.

Molecular Signature of Pancreatic Precursors Revealed by Single-Cell RNA Sequencing {#sec2.5}
-----------------------------------------------------------------------------------

To investigate the molecular basis of the observed functional heterogeneity of pancreatic precursors, we turned to single-cell RNA-seq, focusing on E13.25 (as a matching time point for the lineage tracing analysis, given the predicted time delay in the expression of Cre \[[@bib7]\]) and E15.25 to investigate whether and how the molecular signature of progenitors evolves during development ([Figures 6](#fig6){ref-type="fig"} and [S7](#mmc1){ref-type="supplementary-material"}). Combining data from E13.25 and E15.25 embryos, we first performed dimensionality reduction by principal-component analysis (PCA). This identified two distinct clusters of cells. Based on the complementary expression of *Epcam* and *Vimentin*, one of these clusters was identified as mesenchyme, while the remaining cluster was pancreatic ([Figures 6](#fig6){ref-type="fig"}A and [S7](#mmc1){ref-type="supplementary-material"}A). Filtering for pancreatic cells, we performed dimensionality reduction by t-distributed stochastic neighbor embedding (t-SNE), which groups together cells of similar gene expression ([@bib38]), followed by k-means clustering of 303 cells. This identified 4 distinct clusters of cells corresponding to an early endocrine-committed cluster (based on *Neurog3* expression) ([Figures 6](#fig6){ref-type="fig"}B and 6D, upper-left), an early (E13.25) and late (E15.25) acinar cluster (*Ptf1a, Cpa1, Myc*) ([Figures 6](#fig6){ref-type="fig"}B upper right, and 6D; [Figures S7](#mmc1){ref-type="supplementary-material"}B and S7C), and a cluster expressing elevated trunk or ductal markers (*Sox9, Hes1, Nkx6-1*) ([Figures 6](#fig6){ref-type="fig"}B lower left, and 6D; [Figures S7](#mmc1){ref-type="supplementary-material"}D and S7E). This pattern of expression was consistent with early lineage commitment of pancreatic cells, as observed from the lineage tracing data.Figure 6Single-Cell RNA Sequencing Analysis Suggests Early Fate Restriction and Ductal Origin of Progenitors(A and B) (A) t-SNE plot obtained from combining 516 single cells from pancreas obtained from n = 7 mice (n *=* 5 embryos at E13.25 and n *=* 2 embryos at E15.25) showing ductal, islet and early (E13.25) and late (E15.25) acinar clusters, as identified by the expression of marker genes shown in (B), *Neurog3* (upper left*), Ptf1a* (upper right and [Figures S7](#mmc1){ref-type="supplementary-material"}B and S7C), and *Sox9* (lower left and [Figures S7](#mmc1){ref-type="supplementary-material"}D and S7E). Lower right of (B) shows *MKi67* proliferation marker expression, showing evidence of segregation of the ductal cluster. Cell color indicates log transformed normalised read counts. Note that clusters of islet and ductal cells overlap at the two time points.(C) Diffusion pseudo-time plot reveals evidence of lineage segregation with ductal cells at the apex of a hierarchy that branches separately into acinar and islet lineages.(D) Expression levels of pancreas genes for individual cells at E13.25 and E15.25.(E) 7-μm-thick pancreatic section immunostained for Sox9, Cpa1, and Ki67 expression reveals molecular heterogeneity within ductal termini, with Ki67+ cells showing reciprocal expression of Sox9 and Cpa1 (blue and red arrows) as well as some cells positive for both markers (yellow arrows), and Sox9+ Ki67-high cells in the trunk areas (white arrows). See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

We then quantified the degree of gene expression variability within individual clusters ([Figure S7](#mmc1){ref-type="supplementary-material"}I--S7L) ([@bib24], see [STAR Methods](#sec4){ref-type="sec"}). This analysis showed that for the ductal cluster, *Sox9 and Cpa1* were heterogeneously expressed ([Figure S7](#mmc1){ref-type="supplementary-material"}I), while *Sox9* was homogeneously expressed in acinar cells ([Figures S7](#mmc1){ref-type="supplementary-material"}K and S7L). *Ngn3* was expressed heterogeneously within the islet cluster ([Figure S7](#mmc1){ref-type="supplementary-material"}J), as previously reported ([@bib3]), while *Ptf1a* showed homogenous expression in the E15.25 acinar cluster ([Figure S7](#mmc1){ref-type="supplementary-material"}L). Notably, the pan-proliferation *MKi67* marker showed significant variation, with the ductal cluster separating into two subclusters of high and low *MKi67* expression ([Figure 6](#fig6){ref-type="fig"}B lower-right corner and [S7](#mmc1){ref-type="supplementary-material"}I).

To resolve the regional basis of molecular heterogeneity, we examined high-resolution images of tissue immunostained for Ki67, Sox9, Cpa1, and Ptf1a. This analysis showed that within ductal termini, both Cpa1 and Sox9 expression levels were elevated, usually reciprocally expressed, and spatially heterogeneous at the cellular scale, with the majority of these cells high in Ki67 ([Figure 6](#fig6){ref-type="fig"}E). These observations were consistent with proliferative acinar lineage-restricted and ductal or islet-restricted self-renewing precursors becoming localized at ductal termini during branching morphogenesis, as suggested by the lineage tracing analysis. Furthermore, we distinguished double positive Cpa1^high^/Sox9^high^ cells ([Figure 6](#fig6){ref-type="fig"}E, yellow arrows), which could constitute the presumptive rare multipotent cells, as suggested by the lineage tracing analysis. Consistent with the literature, within the trunk areas, we also observed Sox9^high^ cells with reduced levels of Ki67 expression ([Figure 6](#fig6){ref-type="fig"}E, white arrows).

To study proliferative heterogeneity, we examined immunostainings of Ki67, Cpa1, and E-cadherin. At E15.25, areas of tissue rich in Cpa1+ cells showed elevated levels of Ki67 expression, consistent with the single-cell sequencing data and the literature ([Figures S7](#mmc1){ref-type="supplementary-material"}I, S7M, and S7N) ([@bib44]). With respect to E-cadherin+Cpa1− branches, we saw a modest degree of enrichment of Ki67^high^ cells at the more peripheral areas of the pancreas at E15.25 ([Figure S7](#mmc1){ref-type="supplementary-material"}M), consistent with the branching morphogenesis program. We also observed heterogeneity of Ngn3 expression, as previously reported, and consistent with the single-cell sequencing data ([@bib3]) ([Figures S7](#mmc1){ref-type="supplementary-material"}Q and S7R). There were no significant variations in Ptf1a expression for both time points within the Cpa1^high^ termini ([Figures S7](#mmc1){ref-type="supplementary-material"}O and S7P).

To further dissect the lineage relationship between the acinar, ductal, and islet cells ([@bib13]) at both E13.25 and E15.25, we employed diffusion pseudo-time (DPT) ordering of the single-cell RNA-seq data. The results were consistent with ductal cells standing at the apex of the lineage hierarchy ([Figure 6](#fig6){ref-type="fig"}C). Consistent with the tracing data, we found *Sox9* expression in both the ductal and acinar cluster, becoming progressively down-regulated in opposition to the up-regulation of *Cpa1* (p \< 5.5 10^−12^ for both, [Figures S7](#mmc1){ref-type="supplementary-material"}F and S7G). Interestingly, *MKi67*-high cells in the ductal cluster plotted on DPT segregate toward the acinar branch, whereas *MKi67*-low cells segregate toward the islet branch ([Figure S7](#mmc1){ref-type="supplementary-material"}H), consistent with ductal- and acinar-committed progenitors residing in the proliferative ductal terminus and islet cells deriving from less proliferative trailing ducts ([Figure 3](#fig3){ref-type="fig"}E). Further segregation of the acinar clusters between E13.25 and E15.25 was consistent with maturation, signaled by the enhanced expression of *amylase* and *Ptf1a*, as well *Aldh1* and *Hes1* ([Figure 6](#fig6){ref-type="fig"}D).

Discussion {#sec3}
==========

Previous studies have resolved the major events in pancreas development from the specification of the central duct, plexus formation, and early side-branching ([@bib32]) to the later stages of ductal expansion ([@bib40]) and the mechanisms of differentiation into the endocrine and exocrine lineages ([@bib44], [@bib16], [@bib37], [@bib33], [@bib19], [@bib18], [@bib29], [@bib8]). However, the functional basis of pancreatic development at the cellular level---ductal branching and acinar proliferation---have remained in question ([@bib35]). Using a quantitative lineage tracing strategy, we have used 3D clonal reconstructions, statistical analysis, and biophysical modeling to define the cellular basis of pancreas morphogenesis.

Our results show that during the secondary transition, the expansion of the ductal network from a central plexus is driven by minority subpopulations of self-renewing precursors localized at active ductal termini ([Figure 7](#fig7){ref-type="fig"}). Through continuous rounds of ductal bifurcation, these distinct precursor populations are segregated between newly formed ductal termini and expanded, leading to rapid monoclonal conversion. After E12.5, the bulk of the expansion of the acinar compartment is brought about by self-renewing acinar-committed precursors. Based on the correlation of the size distribution and spatial organization of ductal and acinar-only clones, it follows that acinar-committed precursors must be co-localized with, and undergo the same dynamics as, self-renewing ductal precursors during bifurcation, in a manner reminiscent of the behavior of lineage-restricted basal and luminal stem cells during the postnatal development of the mouse mammary gland epithelium. However, in contrast to the overwhelming unipotency of acinar precursors, at E12.5, most self-renewing ductal precursors still retain multipotency. This hypothesis is reinforced by single-cell RNA-seq and complements the findings of Zhou et al. ([@bib44]) on how multipotent ductal precursors guide early organogenesis. In particular, these findings show that during the later phase of organogenesis, the growth potential of cells residing at ductal termini, and thus their contribution to branching morphogenesis, is not correlated with their lineage potential.Figure 7Summary Schematics Depicting Morphogenic Events during the Second Phase of Pancreatic DevelopmentPancreas morphogenesis follows from a process of stochastic ductal bifurcation and termination driven by self-renewing fate-restricted ductal and acinar precursors, as well as rarer tripotent precursors, which become depleted after E15.5. The figure presents the potential evolution of a single labeled mCFP+ ductal precursor, cYFP+ acinar precursor, and cRFP+ tripotent precursor. The pink area denotes proliferatively active cells in ductal termini.

Lately, a similar clonal lineage tracing strategy was used to address the earliest phase of pancreas development, tracing clonal dynamics from E9.5 to E14.5 ([@bib21]). Although the findings of Larsen et al. are in general qualitative agreement with the current study, the relative abundance of individual clone types contrasts with the present findings. Several factors may contribute to this apparent discrepancy: first, since Larsen's study made use of a 4OH-Tamoxifen administration protocol, the actual induction time may differ by as much as a day between the two studies. Second, to assess potency, Larsen et al. make use of markers that are lineage-unspecific at E14.5. In particular, previous studies have shown that at E14.5 and until birth, cells positive for the ductal marker Sox9 may give rise to all the pancreatic lineages ([@bib19], [@bib37], [@bib11]). Similarly, Cpa1, used by Larsen et al. as a marker of mature acinar fate, has been shown to mark multipotent progenitors at the lineage level at least until E14 ([@bib44]). Finally, it has been shown that a fraction of Ngn3+ endocrine-associated precursors may revert to ductal and acinar fate ([@bib41], [@bib4]). Therefore, with an early collection time point, some labeled cells may be unresolved into lineages, whereas others may have already committed to a definitive fate outcome but not yet up-regulated their corresponding lineage markers.

In summary, we propose that the large-scale organization of the pancreas is coordinated by a process of ductal end-driven branching morphogenesis, which may continue in concert with central plexus remodeling ([@bib3]). In this paradigm, the proliferative potential of precursors is not specified early in development but emerges from chance collective fate decisions made during branching morphogenesis. The statistical properties of the pancreatic ductal network are predicted quantitatively by a model in which ductal termini function as distinct niche-like domains, self-renewing through stochastic dichotomous branching until they terminate when in proximity with neighboring ducts. These dynamics mirror closely the quantitative behavior resolved in the mouse mammary gland and kidney ([@bib14]), providing evidence for a conserved paradigm of branching morphogenesis in different mammalian tissues. Based on the current findings, we conclude that the regulation of ductal branching and termination are not directed by autonomous cell-fate decisions but occur cooperatively at the level of ductal termini via negative growth signals. Interestingly, a related model based on similar short-range inhibition was used recently to explain branching patterns in pancreatic organoids ([@bib6], [@bib5]). How environmental and signaling factors regulate these collective cellular decisions to promote ductal branching and termination thus remains an interesting question for future studies, as does the spatio-temporal interplay between branching morphogenesis, central plexus remodeling, and islet formation ([@bib3]).

The capacity of precursors to act cooperatively to achieve long-term self-renewal while giving rise to more differentiated progeny suggests that these cells may rely on regulatory programs similar to those borne by adult stem cell populations. Indeed, the controlled duplication of the self-renewing pool following ductal bifurcation suggests that the regulation of precursor number may be linked to localized factors at ductal termini, which constitute a closed niche environment. Resolving these factors will form the focus of future investigations.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Chromogranin AAbcamCat\# ab15160AmylaseSanta CruzCat\# sc-12821Ki67Thermo FisherCat\# 14-5698-82E-cadherinBD BiosciencesCat\# 610181E-cadherinAbcamCat\# ab11512Ngn3Santa CruzCat\# sc-13793Cpa1RD systemsCat\# AF2765Sox9MilliporeCat\# AB5535Ptf1aBertrand Blondeau ([@bib30])N/ADolichos biflorus agglutinin (DBA), biotinylatedVectorlabsCat\# B-1035Tie2-APCBiolegendCat\# 124010CD45-FITCBiolegendCat\# 103108**Chemicals, Peptides, and Recombinant Proteins**TamoxifenSigmaCat\# T5648-1GCorn oilSigmaCat\# C8267EdUThermoFisher ScientificCat\# A10044TrypleThermoFisher ScientificCat\# A1217702RapiClear 1.52SunJin LabCat\# RC152001**Critical Commercial Assays**EdU Click-iT Alexa Fluor 488 Imaging kitLife technologiesCat\# C10337Nextera XT DNA Preparation KitIlluminaCat\# FC-131-1096**Deposited Data**Mapped reads from single-cell RNA sequencing analysisThis paperNational Center for Biotechnology Information GEO -accession number GEO: [GSE89798](ncbi-geo:GSE89798){#interref0010}Experimental Models: Organisms/Strains*Mouse*: *Rosa26*-CreERT2; *Rosa26*-Confetti (pancreatic tissue)[@bib22], [@bib39]N/A*Mouse*: *Sox9*-CreERT2 ([@bib19]) (pancreatic tissueThe Jackson Laboratory018829 strain**Software and Algorithms**VolocityPerkin ElmerN/AImarisBitplaneN/APrism 7GraphpadN/AR's statistics packageN/AN/Ascater package[@bib25]N/Ascran package[@bib23]N/Adestiny packageLaleh Haghverdi et alN/AG-SNAP[@bib43]N/A

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to, and will be fulfilled by, the Lead Contact, Benjamin D. Simons (<bds10@cam.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

*Rosa26*-CreERT2, and *Rosa26*-Confetti mice were described previously ([@bib22], [@bib39]). *Sox9*-CreERT2 ([@bib19]) mice were obtained from The Jackson Laboratory (018829 strain). Littermates were housed together and tissues collected before weaning. Since we did not find gender differences in the clonal data, results from mice of mixed gender were pooled. All mice were housed under specific pathogen-free conditions and all procedures were performed according to United Kingdom Home Office regulations. This research has been regulated under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the University of Cambridge Animal Welfare and Ethical Review Body (AWERB).

Method Details {#sec4.4}
--------------

### Induction of Lineage Tracing {#sec4.4.1}

Tamoxifen (Sigma, T5648-1G) was prepared at 10mg/ml in corn oil (Sigma, C8267). Mice were intraperitoneally injected with Tamoxifen at 0.020, 0.025, 0.015 and 0.010mg per gram of pregnant female for E9.5, E12.5, E15.5 and E18.5 induction respectively. Analysis of pancreas from non-injected mice confirmed that *Rosa26*-CreERT2/*Rosa26*-Confetti and *Sox9*-CreERT2/*Rosa26*-Confetti system were not leaky ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2D)

### EdU Administration {#sec4.4.2}

EdU (ThermoFisher Scientific, A10044) was prepared at 10mg/ml in PBS. For EdU administration, mice were intraperitoneally injected at 20μg per gram of pregnant female.

### Tissue Preparation {#sec4.4.3}

Embryonic and neonatal pancreas was fixed in 4% Paraformaldehyde (PFA) from 45 minutes to overnight, dependent on its developmental stage, and then washed in PBS extensively. For cryostat sectioning, samples were sucrose-equilibrated (30%) and mounted in OCT, and subsequently 100μm cryostat sectioned, or 7μm cryostat sectioned for [Figures 6](#fig6){ref-type="fig"} and [S7](#mmc1){ref-type="supplementary-material"}.

### Tissue Staining {#sec4.4.4}

Thick 100μm cryostat sections were rehydrated in PBS. Sections and whole mount pancreata were blocked overnight in PBS, 2% donkey serum and 0.5% Triton-100X. The samples were incubated in primary antibodies (Chromogranin A from Abcam, ab15160 and Amylase from Santa Cruz, sc-12821) and Dolichos biflorus agglutinin (DBA), biotinylated (from Vectorlabs, B-1035) for 3 days at 4°C. Secondary antibodies were applied (from Life Technologies) and in AF647-Streptavidin (from Life Technologies) for 2 days at 4°C. EdU staining was performed on whole mount pancreata using EdU Click-iT Imaging Kit, according to the manufacturer's instructions (Life technologies, C10337), but with extended incubation of 5 hours at room temperature. Following the staining, all tissues were cleared with RapiClear 1.52 (from SunJin Lab, RC152001).

Thin sections were incubated in 2% Serum, 0.1% Triton-100X in PBS for 30 mins, subsequently incubated in primary antibody in 0.01%Triton-100X in PBS overnight (Ki67 from Thermo Fisher 14-5698-82, E-cadherin from BD Biosciences 610181, E-cadherin from Abcam ab11512, Ngn3 from Santa Cruz sc-13793, Cpa1 from RD systems AF2765, Sox9 from Millipore AB5535 and Ptf1a from Bertrand Blondeau ([@bib30]), washed 3 times for 10 minutes the next day, and incubated with secondary antibody in 0.01%Triton-100X for 3 hours, washed and mounted.

### Confocal Microscopy and Image Analysis {#sec4.4.5}

Images of whole mount and thick section pancreas were acquired using Leica TCS SP5 confocal microscope, using the tiling module. The images were analyzed with Volocity software. Parameters from imaged tissue such as volumes of objects, the 3D (x,y,z) coordinates of centers of objects, as well as tissue boundary points were recorded. By setting intensity thresholds manually for every image, the differently colored clusters were identified and the required parameters computed by the software. Information about the cluster constituent cell types was collected by looking at co-localization of clusters with a pancreatic marker in the Z-layer mode of Volocity. To obtain 3D reconstructed images from Z stacks from an image captured by the Leica SP5 microscope, Imaris management software (v8, Bitplane) was used.

### Cell Fate Assessment {#sec4.4.6}

All images were analyzed. The fate assignment was based on DAPI, DBA and Chromogranin A stainings, and amylase in additional experiments (n=53 clones, 4 mice). To assess clonality with confidence, it was important to make use of the four-color confetti reporter system. As a result, it was necessary to image Chromogranin A and DBA in the same color channel. Nevertheless, ductal and islet cell types could be readily distinguished by morphology. The integrity of these cell-type assignments were verified by separate experiments co-staining with different colors: DBA and Chromogranin A; DBA and amylase; DBA, chromogranin A and amylase ([Figure S4](#mmc1){ref-type="supplementary-material"}). Furthermore through careful optimization, the islets and ducts were stained and imaged at different and exclusive intensity ranges, as demonstrated in [Figures S4](#mmc1){ref-type="supplementary-material"}D--S4F. The visualization reveals a close overlap between the heatmap and bimodal presentations (based on intensity) of ducts and islets within the same channel when compared with ducts and islets stained in two distinct and wave length-distant imaging channels.

To test more directly that cell identity could be reliably discriminated based on these markers, and, in particular, that acinar and ductal cells could be distinguished, the lineage tracing experiment was repeated from E12.5 to P14, and clones imaged together with amylase, DBA and chromogranin A co-staining. *53* clones were quantified ([Figures 1](#fig1){ref-type="fig"}M, [S2](#mmc1){ref-type="supplementary-material"}O, S2P, and [S3](#mmc1){ref-type="supplementary-material"}), and tested for whether the potency distributions (segregated into unipotent, bipotent and tripotent) were same as that observed in the original tracing. Crucially, no statistically significant difference (P=0.37, chi-square test) was found between the two sets of experiments. We also segregated both datasets to compare specifically the potency of acinar-containing clones in each. Similar to our results on global potency comparisons, we found no statistically significant differences (P=0.38, chi-square test)

### Single-Cell RNA Sequencing {#sec4.4.7}

E13.25 and E15.25 pancreatic buds were collected from embryos of *n = 5* and *n = 2* pregnant females, respectively, and cells were dissociated in TrypLe-5X (ThermoFisher Scientific, A1217702) for 10 minutes at 37°C and the cell suspension immunostained. Single cells were individually sorted by fluorescence-activated cell sorting into wells of a 96-well polymerase chain reaction plate containing lysis buffer, with negative selection against blood cell marker Tie2-APC (clone Tek4, Cat: 124010, Biolegend), endothelial marker CD45-FITC (from clone 30-F11, Cat: 103108, Biolegend) and DAPI. scRNA-seq analysis was performed as described previously ([@bib42], [@bib31]). The Illumina Nextera XT DNA Preparation Kit (Illumina, FC-131-1096) was used to prepare libraries. Pooled libraries were sequenced using the Illumina HiSeq 4000 system (single-end 50 bp reads). Reads were aligned using G-SNAP ([@bib43]) and the mapped reads were assigned to Ensembl genes (release 81) ([@bib10]) by HTSeq ([@bib1]).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Statistics Reporting {#sec4.5.1}

In [Figures 1](#fig1){ref-type="fig"}K--1M, [2](#fig2){ref-type="fig"}G and 2H, [3](#fig3){ref-type="fig"}C and 3D, [4](#fig4){ref-type="fig"}D, [S2](#mmc1){ref-type="supplementary-material"}F--S2J, S2P, [S5](#mmc1){ref-type="supplementary-material"}A and S5B, [S6](#mmc1){ref-type="supplementary-material"}A--S6D, and S6G--S6J, *254* clones induced at E12.5 and traced until P14 were scored from *n*=3 mice. In [Figures 1](#fig1){ref-type="fig"}K, [S5](#mmc1){ref-type="supplementary-material"}F--S5H, and [S6](#mmc1){ref-type="supplementary-material"}E--S6H, 41 clones induced at E9.5 and traced until P14 were scored from *n*=3 mice. Error bars represent mean and S.D. or S.E.M. (outlined in Figure legends). Representative images from [Figures 1](#fig1){ref-type="fig"}C--1J, [2](#fig2){ref-type="fig"}B, 2C, 2I, 2J, [5](#fig5){ref-type="fig"}C, and [S1](#mmc1){ref-type="supplementary-material"}B--S1O are based on observations from *n*=3 mice. Representative images from [Figures 3](#fig3){ref-type="fig"}A and 3B and [S5](#mmc1){ref-type="supplementary-material"}K--S5O are based on observations from *n*=4 mice. Representative images from [Figures 3](#fig3){ref-type="fig"}F,3G, 3H, and [4](#fig4){ref-type="fig"}A are based on observations from *n*=3 mice, each. In [Figures 4](#fig4){ref-type="fig"}I,4K, 4M representative images are based on observation from *n=3, 3, and 4* mice respectively. In [Figures 5](#fig5){ref-type="fig"}F--H, 5I and 5J, [S2](#mmc1){ref-type="supplementary-material"}A--S2D, [S3](#mmc1){ref-type="supplementary-material"}, and [S4](#mmc1){ref-type="supplementary-material"}, representative images were based on *n=2, 2, 3, 4, and 6* mice respectively. Representative images from 6E, S7M-R are based on observations from *n*=3 mice.

In [Figure S2](#mmc1){ref-type="supplementary-material"}M, pancreas mass was measured for *n*=3 mice (E18), *n*=5 mice (P7), *n*=11 mice (P14) and *n*=4 mice (P28). Error bars represent mean and S.E.M. In [Figure S2](#mmc1){ref-type="supplementary-material"}N pancreas length, width and height were measured for *n*=3 mice (E13), *n*=3 mice (P14) and *n*=3 mice (P28). Error bars represent mean and S.E.M. In [Figures 4](#fig4){ref-type="fig"}C, 4D, and 4G and [S6](#mmc1){ref-type="supplementary-material"}B, S6C, S6E, S6F, and S6I subtree sizes were measured for *n*=3 mice and *43* independent subtrees. Error bars represent mean and S.D.

In [Figures 6](#fig6){ref-type="fig"}A--6D and [S7](#mmc1){ref-type="supplementary-material"}A--S7L, 516 single cells were isolated from *n*=7 mice for the single-cell RNA sequencing (*n=5* for E13.25 and *n=2* for E15.25). In [Figures S5](#mmc1){ref-type="supplementary-material"}D and S5E, 84 clones induced at E12.5 and traced until P28 were scored from *n*=2 mice. Error bars represent mean and S.D. In [Figures 5](#fig5){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}N, 78 clones induced at E15.5 and traced until P14 were scored from *n*=2 mice. In [Figures 5](#fig5){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}O, 70 clones induced at E18.5 and traced until P14 were scored from *n*=2 mice. In [Figures 1](#fig1){ref-type="fig"}N and [S2](#mmc1){ref-type="supplementary-material"}O 53 clones induced at E12.5 and traced until P14 were scored from *n*=4 mice.

### Computational Analysis of Sequence Reads {#sec4.5.2}

To identify poor quality cells, three metrics were used: (1) the proportion of aligned reads, (2) the number of endogenous reads and (3) the number of features with more than 1 read. We filtered for cells with (1) more than 20% aligned reads, (2) more than 200,000 endogenous reads and (3) more than 5000 detected features. We only considered genes that were detected in at least 2 cells, with a variance greater than 0.001.

Out of the 672 cells that were captured in the experiment, 516 (77%) were used for downstream analysis. Reads were normalized using the deconvolution method as implemented in the scran package ([@bib23]).

Dimensionality reduction was then performed using PCA as implemented in the scater package ([@bib25]), resulting in two distinct groups of cells. Using the epithelial marker *Epcam*, one of these clusters was identified as being composed of pancreatic cells (303 cells). Focusing on the pancreatic cells alone, t-SNE was performed ([@bib20]) followed by k-means clustering from R's statistics package on the 500 most variable genes to identify the cellular identity of cells in the three clusters using known markers for acinar, ductal and islet cells.

To identify co-varying genes, Spearman's $\rho$ was computed for a list of genes which, as per the literature, are associated with pancreatic development, and $2 - \rho$ was used as a dissimilarity index for hierarchical clustering. Using the destiny package ([@bib2]), a diffusion map (parameters: sigma=95, k=302) was employed and the DPT function was used to arrange cells in pseudo-time. Three distinct branches were identified and, based on the expression of proliferation markers (such as *Mki67*) and various specification and differentiation markers (such as *Cpa1* or *Neurog3*), the branch containing sample "SLX-11256.N701_S506" was identified as the one "earliest" in its developmental stage and used as a starting point to calculate the diffusion pseudo-time.

For the analysis of biological variance of gene expression, for each cluster and gene, the total variance was decomposed into technical and biological components using the trendVar and decomposeVar functions of the scran package ([@bib24]).

### Statistical Analysis of the Clonal Data {#sec4.5.3}

Given the observed cohesiveness of clones and relatively low labeling fraction used in the confetti lineage tracing assay, the spatial x,y and z coordinates of individual clones were first manually assessed, as well as their relative volume in terms of acinar, ductal and islet compartments (for the E9.5 to P14, E12.5 to P14 and E12.5 to P28 tracings). Detailed information for all tracings considered is supplied in a [Table S1](#mmc2){ref-type="supplementary-material"}. All the plots presented in the main and supplemental figures were performed in Prism 8 (Graphpad).

The clonality of our manual reconstructions was challenged in several ways. Taking advantage of the fact that cells were labeled in four different colors (CFP, RFP, GFP and YFP), the probability of finding two clones of the same color at a given distance for all clonal pairs in a given pancreas was computed. It was reasoned that if clonal fragmentation had been underestimated in our reconstructions, then there should be an excess of clones of the same color at small distances (i.e. these would be fragments of the same clones that should be pooled together in a single unit). In the converse case, there should be a lack of clones of the same color at small distances. In the ideal case of a perfect clonal assay, all clones should have been independently induced, so that the probability of finding clones of the same color should be independent of distance, i.e. *P(r)* constant. In order to statistically assess such clonality, it was therefore necessary to build statistically upon what the null-hypothesis would give, i.e. "our assay is clonal".

In order to rescale the probability of finding two clones of the same color at a given distance, and in order not to be influenced by the complex shape and convolution of the pancreas, the probability of finding two clones of any color at a given distance was computed and used to rescale the probability of finding two clones of the same color. In the clonality hypothesis, clones are considered independent, so the resulting rescaled probability should be independent of distance. Next, a non-parametric bootstrapping method was used to build confidence intervals on the prediction from the null hypothesis. Thus, for each individual pancreas, the probability for a clone to have one of the four confetti colors was calculated, and colors of clones were randomly re-assigned according to this average property. This procedure was performed 1000 times, and in each case the rescaled probability *P(r)* was calculated. Finally, a 95% confidence interval at each distance *r* was calculated from this resampled probability distribution to assess how much experimental deviation of *P(r)* from a constant value can be due to random statistical variations. In [Figure S2](#mmc1){ref-type="supplementary-material"}F these confidence intervals for each individual mouse induced at E12.5 and traced until P14 were plotted, together with the experimental measurements of *P(r)*. Notably, the experimental probabilities, although showing statistical variations, were found to be consistently included within the 95% confidence interval from the null-hypothesis; although, in some mice (such as mouse 1), a statistically significant excess of clones of the same color at short distances was observed. Thus, statistical correction was performed for this bias by grouping all clones of the same color within a given radius, in order to get back to the probability value expected from clonal induction (values shown by black dashed lines in [Figure S2](#mmc1){ref-type="supplementary-material"}F).

To further test the clonality of the data, two independent controls were performed. First, it was noticed that one of the mice was stochastically induced at a dose twice as low as its two other counterparts ([Figure S2](#mmc1){ref-type="supplementary-material"}G). The potency data was therefore segregated for each individual mouse in order to check whether the labeling dose influenced our results. For instance, one could have assumed that tripotency observed in the data resulted from unwanted merger of independent clones. Notably, however, the potency described in the main text was found to be faithfully reproduced for each individual mouse ([Figure S2](#mmc1){ref-type="supplementary-material"}I), lending additional credence to our results.

Second, it was also noticed that the four confetti colors were represented in very different proportions ([Figure S2](#mmc1){ref-type="supplementary-material"}H, with all three mice grouped for this statistical assay). In particular, there were more than 5 times as many RFP clones than CFP clones, with GFP and YFP clones sitting at an intermediate probability. The potency data was therefore segregated for each individual color, and it was found that that the degree of unipotency was independent of the color examined ([Figure 1](#fig1){ref-type="fig"}L) and that, in general, the ratio of unipotency, bipotency and tripotency were consistent in all colors examined ([Figure S2](#mmc1){ref-type="supplementary-material"}I). This, again, argues strongly in favor of the clonality of the data, given that CFP cells consisted of less than 0.3% of all pancreatic cells.

Finally, to compare the rescaled distributions of clone sizes at different time points, as well as the clone size versus subtree size distribution in the theory and pancreas subtree data, a Mann-Whitney test was used and P-values reported. (Binning was used for very small clone sizes, as the distribution for rescaled acinar clone size reached much smaller values than ductal clone and subtree size distributions.) In all cases, P-values were also calculated from two-sample Kolmogorov-Smirnoff tests to check our results: 1. rescaled ductal versus acinar compartment size distribution at P14: P=0.68, Mann-Whitney test and P=0.18, Kolmogorov-Smirnoff test; 2. rescaled ductal compartment size distribution at P14 versus P28, P=0.95, Mann-Whitney test, P=0.44, Kolmogorov-Smirnoff test; 3. rescaled acinar compartment size distribution at P14 versus P28, P=0.63, Mann-Whitney test, P=0.78, Kolmogorov-Smirnoff test; 4. Rescaled ductal compartment (P14) versus subtree size distribution, P=0.6, Mann-Whitney test, P=0.34, Kolmogorov-Smirnoff (note that here we excluded small-unbranched clones, as we wished to assess the large-scale heterogeneity from branching morphogenesis); 5. distribution of number of branches per clone induced at E12.5 versus E15.5: P=0.01, Mann-Whitney test, P=0.04, Kolmogorov-Smirnoff test ([Figure S5](#mmc1){ref-type="supplementary-material"}I); 6. distribution of the number of branches per clone (induced at E12.5, [Figure S5](#mmc1){ref-type="supplementary-material"}C) -- center (inner two-thirds of the pancreas) versus periphery (outer third of the pancreas): P=0.007, Mann-Whitney test, P=0.04, Kolmogorov-Smirnoff test.

Quantile-quantile plots were also computed to compare the coefficient of determination R^2^ of to the predicted curve, *f(x)=x*, if the distributions were perfectly identical. It was found that R^2^=0.87 for the E18 subtree size distribution versus the P14 acinar clone size distribution, R^2^=0.83 for the E18 subtree size distribution versus the P14 ductal clone size distribution, and R^2^=0.99 for the P14 acinar clone size distribution versus the P14 ductal clone size distribution ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6C). Moreover, it was found that R^2^=0.89 (respectively R^2^=0.93) when comparing the P14 acinar (respectively ductal) clone size distribution versus the subtree size distribution measured for mammary gland branching morphogenesis ([Figures S6](#mmc1){ref-type="supplementary-material"}I and S6J). (Data from mammary gland was acquired from [@bib34].) These findings are indicative of a close correspondence between the shape of these various distributions; although small differences are bound to arise naturally, for example, due to differential dynamics in ductal and acinar precursors on the background of branching morphogenesis, or specific geometric constraints in mammary gland compared to pancreatic branching morphogenesis.

Note that for the E15.5 to P14 and E18.5 to P14 tracings, the potency was only assessed via the same methods as described before. In order to ensure clonality, given that the density of labeled clones was higher, only the rare colors were used in the quantifications of [Figure 5](#fig5){ref-type="fig"}E (CFP and GFP, see [Figures S6](#mmc1){ref-type="supplementary-material"}N and S6O).

For details on the theoretical analysis of branching morphogenesis, the comparison between model and experiment, and the theoretical analysis of monoclonal conversion during branching morphogenesis, see [Methods S1](#mmc1){ref-type="supplementary-material"}.

Data and Software Availability {#sec4.6}
------------------------------

The accession number for the mapped reads from single-cell RNA sequencing analysis reported in this paper has been uploaded to National Center for Biotechnology Information GEO (accession number GEO: [GSE89798](ncbi-geo:GSE89798){#intref0045}).

Supplemental Information {#app2}
========================

Document S1. Figures S1--S7 and Methods S1, Related to STAR MethodsTable S1. Raw Data of Clonal Quantification within Thick 100-μm Sections Containing Clone Potency, Clone Size, Volumes, Coordinates, Clonal Bound Dimensions, Surface Areas, and Longest Axis in Tab, Related to Graphs in Figures 1, 2, 3, 4, and 5 and Computational Modeling(1) E12.5 to P14, (3) E12.5 to P28, and (5) E9.5 to P14 lineage tracings; as well as the respective coordinates of points on the periphery of each thick section for tabs (2), (4), and (6).Document S2. Article plus Supplemental Information

The authors would like to thank Peter Humphreys for help with image capture, processing, and analysis; Evangelia Diamanti for mapping sequencing data and producing QC plots; Maike Paramor and Joaquin Martinez Herrera for single-cell RNA sequencing sample submission and advice; Chiara Cossetti for FACS sorting; Heather Large and Julie Soffe for animal maintenance; Kenneth Jones for help, support and advice with animal colony management, and Bertrand Blondeau for providing the Ptf1a antibody. This work was supported by the Wellcome Trust (grant numbers 098357/Z/12/Z, B.D.S.; 110326/Z/15/Z, E.H.; and 097922/Z/11/Z, B.G.), Clinical Research Infrastructure Single-cell Facility (MR/M008975/1, B.G.), the MRC (MR/K018329/1, A.P.), and the Rosetrees and Stoneygate Trusts. A.P., M.K.S., and S.N. are MRC funded. E.H. is funded by a Junior Research Fellowship from Trinity College, Cambridge, a Sir Henry Wellcome Fellowship from the Wellcome Trust, and the Bettencourt-Schueller Young Researcher Prize for support. M.H. is a Sir Henry Dale fellow and is jointly funded by the Wellcome Trust and Royal Society (104151/Z/14/Z). This project received support through core funding of the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute (097922/Z/11/Z).

Author Contributions {#app3}
====================

B.D.S., A.P., M.K.S., and E.H. designed the experiments. M.K.S. performed all the experiments, and R.A. contributed to [Figures 6](#fig6){ref-type="fig"} and [S7](#mmc1){ref-type="supplementary-material"}. S.N. prepared cDNA libraries for single-cell RNA-seq, and B.G. guided the single-cell sequencing experiments. M.H. and C.J.H. contributed to Sox9*-*Cre lineage tracing experiments, and J.N. was involved in the optimization of *Rosa26*-lineage tracing experiments. E.H., S.R., and M.K.S. performed analyses. M.K.S. and E.H. made the figures. A.P. and B.D.S. supervised the study. All authors discussed results and participated in the preparation of the manuscript.

Declaration of Interests {#sec5}
========================

The authors declare no competing interests.

Supplemental information includes seven figures, one table, and four videos and can be found with this article online at [https://doi.org/10.1016/j.devcel.2018.06.028](10.1016/j.devcel.2018.06.028){#intref0050}.

[^1]: Lead Contact
